A case report of pseudohypoaldosteronism type 1 initially misdiagnosed as congenital adrenal hyperplasia in a 3-month-old infant
MedPharmRes · 2025
DOI: 10.32895/mpr.25.00011 ↗Kurz gefasst
Fallbericht in der Zeitschrift MedPharmRes, 2025. Verfasst von Lan Thi Chi Huynh und 2 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Pseudohypoaldosteronism type 1 (PHA1) is a rare and serious disorder caused by aldosterone resistance, leading to significant disturbances in electrolyte balance. Due to overlapping clinical manifestations, it is frequently misidentified as congenital adrenal hyperplasia (CAH), resulting in unnecessary corticosteroid therapy. We reported on the case of a 3-month-old infant who had been initially diagnosed and treated for CAH due to severe salt-wasting symptoms. Further biochemical evaluation and genetic analysis later confirmed PHA1. The patient achieved clinical stabilization with fludrocortisone and sodium supplementation. This case underscored the necessity of differentiating PHA1 from CAH through repeated biochemical assessments and genetic testing to ensure an accurate diagnosis and appropriate treatment strategy.
Zitieren
APA
Huynh, L. T. C., Nguyen, T. H., & Vo, T. T. T. (2025). A case report of pseudohypoaldosteronism type 1 initially misdiagnosed as congenital adrenal hyperplasia in a 3-month-old infant. MedPharmRes. https://doi.org/10.32895/mpr.25.00011
Vancouver
Huynh LTC, Nguyen TH, Vo TTT. A case report of pseudohypoaldosteronism type 1 initially misdiagnosed as congenital adrenal hyperplasia in a 3-month-old infant. MedPharmRes. 2025. doi:10.32895/mpr.25.00011
BibTeX
@article{Huynh2025,
author = {Huynh, Lan Thi Chi and Nguyen, Trung Hieu and Vo, Trang Thi Thanh},
title = {A case report of pseudohypoaldosteronism type 1 initially misdiagnosed as congenital adrenal hyperplasia in a 3-month-old infant},
journal = {MedPharmRes},
year = {2025},
doi = {10.32895/mpr.25.00011}
}
EUVIMED